Dobutamine Injection

Product Description

Packing : 20 ml Vial, 5 ml Ampoule.
Available Strength : 250 mg, 20 ml, 40 mg/ml

Dobutamine Injection is a cardiac stimulant and inotropic agent manufactured by Montage Laboratories Pvt. Ltd. It is widely used to increase cardiac output, improve myocardial contractility, and enhance blood flow in patients with acute heart failure, cardiogenic shock, or severe cardiac decompensation. By stimulating beta-1 adrenergic receptors, Dobutamine helps strengthen heart contractions without significantly increasing heart rate, making it ideal for improving cardiac performance.

Administered via intravenous (IV) infusion, it provides rapid and effective cardiovascular support, especially in critical care and emergency situations under close medical supervision.

Montage Laboratories Private Limited

Country/Region:

India
On CPHI since:

2023
Certificates:

3
Employees:

250 - 499

Company types

Manufacturer/Innovator

Pharmaceutical company

Primary activities

Animal Health

Contract Manufacturer

Finished Formulation products Distributor/Buyer

Marketing Services Provider

Nutraceuticals

Pharmaceutical Company (generic finished products)

Compare Add to favorites Added to favorites

Specifications

Details

Product Description : Dobutamine Injection is a sterile, non-pyrogenic, and clear, colorless solution used for intravenous administration. It belongs to the class of medications known as sympathomimetic amines and is primarily used for its inotropic effect, enhancing cardiac contractility.

Indications and Usage : Dobutamine Injection is indicated for the short-term treatment of patients with cardiac decompensation due to depressed contractility, resulting from organic heart disease or surgical procedures. It is particularly useful in conditions such as congestive heart failure and cardiogenic shock.

Dosage and Administration : The dosage of Dobutamine Injection should be individualized based on the patient's condition, response to therapy, and concurrent medications. It is administered intravenously by continuous infusion, typically starting at a low dose and titrating upwards based on the patient's hemodynamic response.